Catheterization Lab Equipment in Pennsylvania

USB Medical is a cardiovascular surgery device manufacturer headquartered in Hatboro, Pennsylvania, specializing in innovative surgical instruments and minimally invasive cardiac solutions. The company develops first-to-market intellectual property in cardiothoracic surgery, with a focus on retraction systems, vascular clamps, and tricuspid valve exposure devices. Key products include the HV Heart Retractor for cardiac exposure, the G2 Detachable Clamp System for vascular control, and the Pulse DEFIR device. USB Medical partners with leading cardiac surgeons globally to design and validate products that enhance procedural safety and efficiency in minimally invasive heart surgery. The company is committed to regulatory compliance and clinical validation of all surgical innovations.

Meril Life Sciences is a global medical device manufacturer headquartered in Vapi, Gujarat, India, and founded in 2006. The company designs and manufactures innovative medical devices across multiple therapeutic specialties including cardiovascular interventions, orthopedic implants, minimally invasive endoscopic surgery tools, surgical robotics, and diagnostics. Meril operates as a multinational enterprise with 100% subsidiaries and regional headquarters spanning North America, Europe, Asia, Africa, and Australia. The company maintains a dedicated research and development function collaborating with surgeons and medical experts worldwide to address unmet clinical needs. Meril's product portfolio includes transcatheter heart valve systems (Myval THV and variants), orthopedic solutions through its Maxx Orthopedics division, endoscopic and minimally invasive surgical instruments, and robotic surgical platforms. The organization emphasizes clinical evidence generation and professional education through Meril Academy, a global platform offering fellowship programs and knowledge-sharing initiatives for healthcare professionals. Manufacturing and distribution capabilities span multiple continents, with established compliance and regulatory frameworks for markets including the United States, European Union, and Asia-Pacific regions. The company serves hospital systems, surgical centers, and healthcare institutions globally, with particular focus on advancing surgical interventions in cancer care and cardiovascular disease management.

Thrombolex, Inc. is a commercial-stage medical device company headquartered in New Britain, Pennsylvania, specializing in endovascular treatment of arterial and venous thromboembolic (A+VTE) conditions. The company develops the BASHIR™ Family of Endovascular Catheters, which employ a hybrid pharmaco-mechanical lysis (PML) platform combining mechanical clot fragmentation with targeted pharmacological thrombolytic delivery. The BASHIR product line includes three main catheter variants: the standard BASHIR Endovascular Catheter (7F and 8F sizes) for peripheral and pulmonary vessels; the BASHIR S-B (short basket) for tortuous and shorter vessel anatomy; and the BASHIR PLUS for extensive thrombus burden with extended infusion capability along the catheter shaft. The company's mechanism uses an expandable infusion basket allowing physician-controlled, selective fluid infusion to optimize clot burden resolution while minimizing systemic exposure to thrombolytics. Thrombolex is conducting active clinical trials including the RESCUE-II study and the RAPID-PE study, which evaluate on-the-table single-session protocols for pulmonary embolism treatment. The company has secured Series A financing and maintains partnerships with diagnostic platforms to advance clinical adoption. Products are marketed to interventional cardiologists and interventional radiologists for acute PE and venous thrombus intervention in hospital-based catheterization labs and interventional suites.

Onocor LLC develops the ŌNŌ transcatheter retrieval system, a specialized device designed for percutaneous removal of embolized, misplaced, or malfunctioning left atrial appendage (LAA) occlusion devices and other structural heart implants. The system addresses a critical clinical need in interventional cardiology and electrophysiology, where device complications from catheter-based structural heart procedures require retrieval without resorting to surgical explantation. The ŌNŌ system operates on a four-step mechanism: receive, align, compress, and remove, enabling physicians to safely retrieve devices from complex anatomical positions, including retrieval from the left ventricular outflow tract. This technology reduces procedural morbidity by eliminating the need for remedial open-heart surgery and serves as a safety net that encourages adoption of less-invasive structural heart interventions. The company is positioned in the interventional cardiology and electrophysiology markets, supporting the growing field of catheter-based structural heart disease management. Clinical validation includes peer-reviewed publication in the Journal of the American College of Cardiology (JACC), documenting first-in-human percutaneous device retrieval cases.

Cagent Vascular is a cardiovascular medical device company pioneering Serration Remodeling Therapy (SRT), a novel vessel preparation technology for interventional cardiology and peripheral vascular applications. The company develops and markets the Serranator, a serration balloon catheter designed to gently remodel arteries, reduce recoil, optimize lumen gain, and improve durable outcomes in angioplasty procedures. The Serranator is effective across all lesion morphologies and is marketed as the first and only serration balloon for blood flow restoration. The company conducts clinical studies demonstrating the technology's efficacy, including data on freedom from clinically driven target lesion revascularization (CD-TLR), recoil mitigation compared to plain old balloon angioplasty (POBA), and low bailout stent rates. Recent product expansion includes 7.0 mm and 8.0 mm balloon sizes. Cagent Vascular positions itself as a leader in angioplasty technology, serving interventional cardiologists and vascular specialists treating cardiovascular disease, a leading cause of mortality worldwide. The company maintains active clinical research partnerships with academic medical centers such as Columbia University Medical Center.

B. Braun Interventional Systems Inc., a subsidiary of the B. Braun Group, designs and manufactures innovative medical devices for interventional procedures, with focus on cardiology and vascular interventions. The company develops solutions across angioplasty and valvuloplasty catheters, congenital and structural heart devices, percutaneous drainage systems, vena cava filters, vascular access devices, and interventional accessories. Products are engineered in collaboration with physicians, technologists, and nurses to enhance patient outcomes, procedural safety, efficiency, and precision. The company operates from its Bethlehem, Pennsylvania facility and serves hospital catheterization laboratories, interventional radiology departments, and specialty centers. Notable product lines include the COMPASS™ Guiding Introducer Sheath, Occlutech® ASD Occluder, NuDEL™ CP Stent® Delivery System, ŌNŌ™ Retrieval Device, and Accel® Drainage Catheter Sets. B. Braun Interventional Systems maintains 24/7 customer support and emergency on-call services. The company holds national contracts and is committed to compliance and ethical business practices within the medical device industry.

VascuTech Medical is an FDA and ISO 13485 registered medical device manufacturer specializing in vascular access devices for interventional radiology, interventional cardiology, pain management, and urology. The company manufactures Class I, II, and III devices including catheters (dialysis, balloon angiography, drug delivery), dilators, sheaths, hemostasis valves, biopsy needles, trocars, tunnelers, and thrombectomy devices. VascuTech provides comprehensive contract manufacturing services spanning product and process development, design engineering, rapid prototyping, pilot production, and full-scale manufacturing. The company maintains vertically integrated in-house fabrication and assembly capabilities with thirty years of combined experience in medical device design and development.

Ambler Surgical is a specialty surgical instrument distributor founded in 1997 and headquartered in Exton, Pennsylvania. The company supplies high-quality surgical instruments manufactured in Germany and the U.S. to surgical facilities worldwide. Ambler Surgical maintains an advanced e-commerce catalog featuring over 8 specialty disciplines: ophthalmology, ENT, hand surgery, plastic surgery, neuro/spinal, cardiovascular, OB/GYN, orthopedic, and general surgery. The company emphasizes customer satisfaction through rapid online navigation, high-resolution product imaging, and comprehensive filtering. Notable offerings include lifetime repair services for ophthalmic instruments, risk-free 30-day evaluation periods, and educational resources on surgical instrument cleaning and infection control. Ambler Surgical participates in major group purchasing contracts with HealthTrust and Vizient, enabling cost-effective sourcing for multi-specialty surgical centers.

Cook Medical is a global manufacturer of minimally invasive medical devices across multiple specialties including cardiology, urology, gastroenterology, otolaryngology, and vascular intervention. The company designs, manufactures, and distributes a broad portfolio of devices for endoscopic procedures, catheterization labs, peripheral and thoracic vascular intervention, and urological applications. Key product lines include endoscopic hemostasis devices (Hemospray®), esophageal balloons (Hercules® 100), microcatheters (Cantata®), ureteral stents (Resonance® Metallic Ureteral Stent Set), endovascular grafts (Zenith Alpha™), and drug-eluting peripheral stents (Zilver® PTX®). The company operates customer portals, maintains comprehensive Instructions for Use databases, and provides formal education and training programs (Vista® Education & Training). Cook Medical serves healthcare systems globally with FDA-cleared and CE-marked devices for minimally invasive therapeutic and interventional procedures. The organization supports MRI-safe device documentation and maintains active regulatory compliance across US and international markets.

Pressure Products Medical Device Manufacturing LLC designs and manufactures specialized vascular access and transseptal intervention devices for interventional cardiology and electrophysiology procedures. The company's product portfolio includes the SafeSept® and SafeSept RF™ transseptal guidewire systems, which enable safe crossing of the interatrial septum at the fossa ovalis with reduced penetration forces and improved procedural safety. SafeSheath® II and SafeSheath® II Long hemostatic peel-away introducers provide vascular access with reduced back bleeding and air embolism risk. These devices are designed for use in interventional labs and catheterization centers. The company serves major health systems and hospital networks across the United States. Products are positioned for transseptal access procedures, which are critical for certain cardiac ablations, structural heart interventions, and left atrial appendage procedures. The SafeSept RF system incorporates radio frequency technology and claims no-exchange vascular access (NEVA) capability with low-power operation (≤10W), representing advancement in procedural workflow efficiency.

Rex Medical LP is a medical device manufacturer specializing in minimally invasive solutions for cardiovascular, venous access, endosurgery, and oncology applications. The company develops and markets innovative devices designed to address unmet clinical needs in these therapeutic areas. Their primary product offering includes the REVOLUTION™ Peripheral Atherectomy System, a device used for peripheral vascular intervention. Rex Medical is ISO 13485 certified, indicating compliance with medical device quality management system standards. The company focuses on delivering high-quality patient care through technology-driven innovation in the minimally invasive medical device sector.

Boehringer Laboratories LLC is a US-based manufacturer of high-quality, precision medical devices serving hospital operating rooms, cardiothoracic programs, and surgical specialties. The company specializes in suction regulators, which have been industry-standard equipment for over 40 years, trusted by top hospital networks for precise vacuum pressure control during surgical procedures. The product portfolio includes the 7700, 7800, 3700, 3800, and 3900 Series Suction Regulators, designed to protect delicate tissues and ensure patient safety with multiple operating modes, accurate pressure settings, and durable, cleanable designs. Boehringer also manufactures the VAVD Controller and VacPac®, precision vacuum-regulation systems explicitly designed for vacuum-assisted venous drainage (VAVD) during cardiopulmonary bypass procedures, featuring redundant safety interlocks and positive interaction controls. The ViSiGi® device is a versatile gastric calibration and decompression system for bariatric surgery (sleeve gastrectomy and bypass), providing precise stomach sizing and enhanced surgical efficiency. CareDry® is an innovative female external catheter for urinary incontinence management, featuring 360-degree suction, antimicrobial foam, and moldable design for up to 48-hour wear. The company maintains factory-trained technical support, repair services (including out-of-warranty repairs), and a comprehensive service manual library. Boehringer operates from its Phoenixville, Pennsylvania headquarters and serves the US hospital market through a regional sales representative network, hospital departments including OR/Surgery, Perfusion, BioMed, Nursing, and Supply Chain. The company accepts orders via email, phone, fax, and credit card, with customer service responding within one business day.